메뉴 건너뛰기




Volumn 787, Issue , 2011, Pages 255-265

Preparation of a Heat-Shock Protein 70-Based Vaccine from DC–Tumor Fusion Cells

Author keywords

Cell fusion; Dendritic cells; Extraction of Hsp70 peptide complexes; Heat shock protein 70; Tumor vaccine

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; RECOMBINANT VACCINE;

EID: 80054765276     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-295-3_19     Document Type: Chapter
Times cited : (14)

References (56)
  • 2
    • 0027333423 scopus 로고
    • Role of the major heat shock proteins as molecular chaperones
    • Georgopolis C., Welch W. J. (1993) Role of the major heat shock proteins as molecular chaperones Ann. Rev. Cell Biol. 9, 601–34.
    • (1993) Ann. Rev. Cell Biol. , vol.9 , pp. 601-634
    • Georgopolis, C.1    Welch, W.J.2
  • 3
    • 0032489016 scopus 로고    scopus 로고
    • The Hsp70 and Hsp60 chaperone machines
    • Bukau B., Horwich A. L. (1998) The Hsp70 and Hsp60 chaperone machines Cell 92, 351–66.
    • (1998) Cell , vol.92 , pp. 351-366
    • Bukau, B.1    Horwich, A.L.2
  • 4
    • 15944373162 scopus 로고    scopus 로고
    • Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo
    • Tang D., Khaleque A. A., Jones E. R., Theriault J. R., Li C., Wong W. H., Stevenson M. A., et al. (2005) Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 10, 46–58.
    • (2005) Cell Stress Chaperones , vol.10 , pp. 46-58
    • Tang, D.1    Khaleque, A.A.2    Jones, E.R.3    Theriault, J.R.4    Li, C.5    Wong, W.H.6    Stevenson, M.A.7
  • 5
    • 0037111218 scopus 로고    scopus 로고
    • Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells
    • Noessner E., Gastpar R., Milani V., Brandl A., Hutzler P. J., Kuppner M. C., Roos M., et al. (2002) Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells J Immunol 169, 5424–32.
    • (2002) J Immunol , vol.169 , pp. 5424-5432
    • Noessner, E.1    Gastpar, R.2    Milani, V.3    Brandl, A.4    Hutzler, P.J.5    Kuppner, M.C.6    Roos, M.7
  • 6
    • 0035925608 scopus 로고    scopus 로고
    • Heat shock proteins: The “Swiss Army Knife” vaccines against cancers and infectious agents
    • Srivastava P. K., Amato R. J. (2001) Heat shock proteins: the “Swiss Army Knife” vaccines against cancers and infectious agents Vaccine 19, 2590–7.
    • (2001) Vaccine , vol.19 , pp. 2590-2597
    • Srivastava, P.K.1    Amato, R.J.2
  • 9
    • 0034994662 scopus 로고    scopus 로고
    • The inducible Hsp70 as a marker of tumor immunogenicity
    • Clark P. R., Menoret A. (2001) The inducible Hsp70 as a marker of tumor immunogenicity Cell Stress Chaperones 6, 121–5.
    • (2001) Cell Stress Chaperones , vol.6 , pp. 121-125
    • Clark, P.R.1    Menoret, A.2
  • 10
    • 0036214288 scopus 로고    scopus 로고
    • Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses
    • Srivastava P. (2002) Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu Rev Immunol 20, 395–425.
    • (2002) Annu Rev Immunol , vol.20 , pp. 395-425
    • Srivastava, P.1
  • 11
    • 3042740948 scopus 로고    scopus 로고
    • Hypothesis: Controlled necrosis as a tool for immunotherapy of human cancer
    • Srivastava P. (2003) Hypothesis: controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun. 3, 4.
    • (2003) Cancer Immun , vol.3 , pp. 4
    • Srivastava, P.1
  • 12
    • 0034328883 scopus 로고    scopus 로고
    • Immunotherapy of human cancer: Lessons from mice
    • Srivastava P. K. (2000) Immunotherapy of human cancer: lessons from mice Nat Immunol 1, 363–6.
    • (2000) Nat Immunol , vol.1 , pp. 363-366
    • Srivastava, P.K.1
  • 13
    • 0037108696 scopus 로고    scopus 로고
    • Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings
    • Belli F., Testori A., Rivoltini L., Maio M., Andreola G., Sertoli M. R., Gallino G., et al. (2002) Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings J Clin Oncol 20, 4169–80.
    • (2002) J Clin Oncol , vol.20 , pp. 4169-4180
    • Belli, F.1    Testori, A.2    Rivoltini, L.3    Maio, M.4    Andreola, G.5    Sertoli, M.R.6    Gallino, G.7
  • 17
    • 39749186213 scopus 로고    scopus 로고
    • Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: The C-100-21 Study Group
    • Testori A., Richards J., Whitman E., Mann G. B., Lutzky J., Camacho L., Parmiani G., et al. (2008) Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician’s choice of treatment for stage IV melanoma: the C-100-21 Study Group J Clin Oncol 26, 955–62.
    • (2008) J Clin Oncol , vol.26 , pp. 955-962
    • Testori, A.1    Richards, J.2    Whitman, E.3    Mann, G.B.4    Lutzky, J.5    Camacho, L.6    Parmiani, G.7
  • 18
    • 46749085802 scopus 로고    scopus 로고
    • An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: A multicentre, open-label, randomised phase III trial
    • Wood C., Srivastava P., Bukowski R., Lacombe L., Gorelov A. I., Gorelov S., Mulders P., et al. (2008) An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial Lancet 372, 145–54.
    • (2008) Lancet , vol.372 , pp. 145-154
    • Wood, C.1    Srivastava, P.2    Bukowski, R.3    Lacombe, L.4    Gorelov, A.I.5    Gorelov, S.6    Mulders, P.7
  • 19
    • 33750359212 scopus 로고    scopus 로고
    • Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells
    • Enomoto Y., Bharti A., Khaleque A. A., Song B., Liu C., Apostolopoulos V., Xing P. X., et al. (2006) Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells J Immunol 177, 5946–55.
    • (2006) J Immunol , vol.177 , pp. 5946-5955
    • Enomoto, Y.1    Bharti, A.2    Khaleque, A.A.3    Song, B.4    Liu, C.5    Apostolopoulos, V.6    Xing, P.X.7
  • 20
    • 0025735629 scopus 로고
    • The dendritic cell system and its role in immunogenicity
    • Steinman R. M. (1991) The dendritic cell system and its role in immunogenicity Annu Rev Immunol 9, 271–96.
    • (1991) Annu Rev Immunol , vol.9 , pp. 271-296
    • Steinman, R.M.1
  • 21
    • 0035347549 scopus 로고    scopus 로고
    • Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation
    • Steinman R. M. (2001) Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation Mt Sinai J Med 68, 106–66.
    • (2001) Mt Sinai J Med , vol.68 , pp. 106-166
    • Steinman, R.M.1
  • 22
    • 0030904482 scopus 로고    scopus 로고
    • Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
    • Gong J., Chen D., Kashiwaba M., and Kufe D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells Nat Med 3, 558–61.
    • (1997) Nat Med , vol.3 , pp. 558-561
    • Gong, J.1    Chen, D.2    Kashiwaba, M.3    Kufe, D.4
  • 23
    • 0036529823 scopus 로고    scopus 로고
    • Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
    • Gong J., Koido S., Chen D., Tanaka Y., Huang L., Avigan D., Anderson K., et al. (2002) Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12 Blood 99, 2512–7.
    • (2002) Blood , vol.99 , pp. 2512-2517
    • Gong, J.1    Koido, S.2    Chen, D.3    Tanaka, Y.4    Huang, L.5    Avigan, D.6    Anderson, K.7
  • 24
    • 0036286494 scopus 로고    scopus 로고
    • Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity
    • Liu Y., Zhang W., Chan T., Saxena A., and Xiang J. (2002) Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity Leuk Res 26, 757–63.
    • (2002) Leuk Res , vol.26 , pp. 757-763
    • Liu, Y.1    Zhang, W.2    Chan, T.3    Saxena, A.4    Xiang, J.5
  • 25
    • 0036992163 scopus 로고    scopus 로고
    • Tumour cell-dendritic cell fusion for cancer immunotherapy: Comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols
    • Lindner M., Schirrmacher V. (2002) Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols Eur J Clin Invest 32, 207–17.
    • (2002) Eur J Clin Invest , vol.32 , pp. 207-217
    • Lindner, M.1    Schirrmacher, V.2
  • 26
    • 0035210399 scopus 로고    scopus 로고
    • Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice
    • Homma S., Toda G., Gong J., Kufe D., and Ohno T. (2001) Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice J Gastroenterol 36, 764–71.
    • (2001) J Gastroenterol , vol.36 , pp. 764-771
    • Homma, S.1    Toda, G.2    Gong, J.3    Kufe, D.4    Ohno, T.5
  • 27
    • 0032781867 scopus 로고    scopus 로고
    • Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
    • Cao X., Zhang W., Wang J., Zhang M., Huang X., Hamada H., and Chen W. (1999) Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells Immunology 97, 616–25.
    • (1999) Immunology , vol.97 , pp. 616-625
    • Cao, X.1    Zhang, W.2    Wang, J.3    Zhang, M.4    Huang, X.5    Hamada, H.6    Chen, W.7
  • 28
    • 0032533837 scopus 로고    scopus 로고
    • Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines
    • Wang J., Saffold S., Cao X., Krauss J., and Chen W. (1998) Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines J Immunol 161, 5516–24.
    • (1998) J Immunol , vol.161 , pp. 5516-5524
    • Wang, J.1    Saffold, S.2    Cao, X.3    Krauss, J.4    Chen, W.5
  • 29
    • 0036334152 scopus 로고    scopus 로고
    • Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion
    • Hayashi T., Tanaka H., Tanaka J., Wang R., Averbook B. J., Cohen P. A., and Shu S. (2002) Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion Clin Immunol 104, 14–20.
    • (2002) Clin Immunol , vol.104 , pp. 14-20
    • Hayashi, T.1    Tanaka, H.2    Tanaka, J.3    Wang, R.4    Averbook, B.J.5    Cohen, P.A.6    Shu, S.7
  • 30
    • 0037442132 scopus 로고    scopus 로고
    • Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells
    • Xia J., Tanaka Y., Koido S., Liu C., Mukherjee P., Gendler S. J., and Gong J. (2003) Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells J Immunol 170, 1980–6.
    • (2003) J Immunol , vol.170 , pp. 1980-1986
    • Xia, J.1    Tanaka, Y.2    Koido, S.3    Liu, C.4    Mukherjee, P.5    Gendler, S.J.6    Gong, J.7
  • 31
    • 0037379315 scopus 로고    scopus 로고
    • Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine
    • Kao J. Y., Gong Y., Chen C. M., Zheng Q. D., and Chen J. J. (2003) Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine J Immunol 170, 3806–11.
    • (2003) J Immunol , vol.170 , pp. 3806-3811
    • Kao, J.Y.1    Gong, Y.2    Chen, C.M.3    Zheng, Q.D.4    Chen, J.J.5
  • 32
    • 0141705384 scopus 로고    scopus 로고
    • Immature dendritic cell/ tumor cell fusions induce potent antitumour immunity
    • Takeda A., Homma S., Okamoto T., Kufe D., and Ohno T. (2003) Immature dendritic cell/ tumor cell fusions induce potent antitumour immunity Eur J Clin Invest 33, 897–904.
    • (2003) Eur J Clin Invest , vol.33 , pp. 897-904
    • Takeda, A.1    Homma, S.2    Okamoto, T.3    Kufe, D.4    Ohno, T.5
  • 33
    • 0037347935 scopus 로고    scopus 로고
    • Antitumor immunopreven-tive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo
    • Zhang J. K., Li J., Zhang J., Chen H. B., and Chen S. B. (2003) Antitumor immunopreven-tive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo World J Gastroenterol 9, 479–84.
    • (2003) World J Gastroenterol , vol.9 , pp. 479-484
    • Zhang, J.K.1    Li, J.2    Zhang, J.3    Chen, H.B.4    Chen, S.B.5
  • 34
    • 0035170777 scopus 로고    scopus 로고
    • Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity
    • Li J., Holmes L. M., Franek K. J., Burgin K. E., Wagner T. E., and Wei Y. (2001) Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity Cancer Immunol Immunother 50, 456–62.
    • (2001) Cancer Immunol Immunother , vol.50 , pp. 456-462
    • Li, J.1    Holmes, L.M.2    Franek, K.J.3    Burgin, K.E.4    Wagner, T.E.5    Wei, Y.6
  • 35
    • 22844441620 scopus 로고    scopus 로고
    • Dendritic cell/myeloma hybrid vaccine
    • Xia D., Chan T., and Xiang J. (2005) Dendritic cell/myeloma hybrid vaccine Methods Mol Med 113, 225–33.
    • (2005) Methods Mol Med , vol.113 , pp. 225-233
    • Xia, D.1    Chan, T.2    Xiang, J.3
  • 37
    • 25444521270 scopus 로고    scopus 로고
    • Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer
    • Kao J. Y., Zhang M., Chen C. M., and Chen J. J. (2005) Superior efficacy of dendritic cell-tumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer Immunol Lett 101, 154–9.
    • (2005) Immunol Lett , vol.101 , pp. 154-159
    • Kao, J.Y.1    Zhang, M.2    Chen, C.M.3    Chen, J.J.4
  • 38
    • 2642557198 scopus 로고    scopus 로고
    • Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-trans-duced, spleen-derived dendritic cells and tumour cells
    • Ogawa F., Iinuma H., and Okinaga K. (2004) Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-trans-duced, spleen-derived dendritic cells and tumour cells Scand J Immunol 59, 432–9.
    • (2004) Scand J Immunol , vol.59 , pp. 432-439
    • Ogawa, F.1    Iinuma, H.2    Okinaga, K.3
  • 39
    • 0035129816 scopus 로고    scopus 로고
    • Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model
    • Akasaki Y., Kikuchi T., Homma S., Abe T., Kofe D., and Ohno T. (2001) Antitumor Effect of Immunizations With Fusions of Dendritic and Glioma Cells in a Mouse Brain Tumor Model J Immunother 24, 106–13.
    • (2001) J Immunother , vol.24 , pp. 106-113
    • Akasaki, Y.1    Kikuchi, T.2    Homma, S.3    Abe, T.4    Kofe, D.5    Ohno, T.6
  • 41
    • 0036877104 scopus 로고    scopus 로고
    • Therapeutic immune response induced by electrofusion of dendritic and tumor cells
    • Tanaka H., Shimizu K., Hayashi T., and Shu S. (2002) Therapeutic immune response induced by electrofusion of dendritic and tumor cells Cell Immunol 220, 1–12.
    • (2002) Cell Immunol , vol.220 , pp. 1-12
    • Tanaka, H.1    Shimizu, K.2    Hayashi, T.3    Shu, S.4
  • 42
    • 0037689451 scopus 로고    scopus 로고
    • Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells
    • Siders W. M., Vergilis K. L., Johnson C., Shields J., and Kaplan J. M. (2003) Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells Mol Ther 7, 498–505.
    • (2003) Mol Ther , vol.7 , pp. 498-505
    • Siders, W.M.1    Vergilis, K.L.2    Johnson, C.3    Shields, J.4    Kaplan, J.M.5
  • 43
    • 0036036401 scopus 로고    scopus 로고
    • Cell fusion: An approach to generating constitutively proliferating human tumor antigen-presenting cells
    • Jantscheff P., Spagnoli G., Zajac P., and Rochlitz C. F. (2002) Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells Cancer Immunol Immunother 51, 367–75.
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 367-375
    • Jantscheff, P.1    Spagnoli, G.2    Zajac, P.3    Rochlitz, C.F.4
  • 44
    • 0037234653 scopus 로고    scopus 로고
    • In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids
    • Goddard R. V., Prentice A. G., Copplestone J. A., and Kaminski E. R. (2003) In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids Clin Exp Immunol 131, 82–9.
    • (2003) Clin Exp Immunol , vol.131 , pp. 82-89
    • Goddard, R.V.1    Prentice, A.G.2    Copplestone, J.A.3    Kaminski, E.R.4
  • 45
    • 0037457018 scopus 로고    scopus 로고
    • Allogeneic dendritic cells fused with tumor cells: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma
    • Marten A., Renoth S., Heinicke T., Albers P., Pauli A., Mey U., Caspari R., et al. (2003) Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma Hum Gene Ther 14, 483–94.
    • (2003) Hum Gene Ther , vol.14 , pp. 483-494
    • Marten, A.1    Renoth, S.2    Heinicke, T.3    Albers, P.4    Pauli, A.5    Mey, U.6    Caspari, R.7
  • 47
    • 19944428075 scopus 로고    scopus 로고
    • Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: Characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells
    • Suzuki T., Fukuhara T., Tanaka M., Nakamura A., Akiyama K., Sakakibara T., Koinuma D., et al. (2005) Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells Clin Cancer Res 11, 58–66.
    • (2005) Clin Cancer Res , vol.11 , pp. 58-66
    • Suzuki, T.1    Fukuhara, T.2    Tanaka, M.3    Nakamura, A.4    Akiyama, K.5    Sakakibara, T.6    Koinuma, D.7
  • 48
    • 14844337815 scopus 로고    scopus 로고
    • Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: Immunological effects and clinical results
    • Trefzer U., Herberth G., Wohlan K., Milling A., Thiemann M., Sharav T., Sparbier K., et al. (2005) Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results Vaccine 23, 2367–73.
    • (2005) Vaccine , vol.23 , pp. 2367-2373
    • Trefzer, U.1    Herberth, G.2    Wohlan, K.3    Milling, A.4    Thiemann, M.5    Sharav, T.6    Sparbier, K.7
  • 49
    • 3042600552 scopus 로고    scopus 로고
    • Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy
    • Shimizu K., Kuriyama H., Kjaergaard J., Lee W., Tanaka H., and Shu S. (2004) Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy J Immunother 27, 265–72.
    • (2004) J Immunother , vol.27 , pp. 265-272
    • Shimizu, K.1    Kuriyama, H.2    Kjaergaard, J.3    Lee, W.4    Tanaka, H.5    Shu, S.6
  • 50
    • 0141461410 scopus 로고    scopus 로고
    • A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines
    • Phan V., Errington F., Cheong S. C., Kottke T., Gough M., Altmann S., Brandenburger A., et al. (2003) A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines Nat Med 9, 1215–9.
    • (2003) Nat Med , vol.9 , pp. 1215-1219
    • Phan, V.1    Errington, F.2    Cheong, S.C.3    Kottke, T.4    Gough, M.5    Altmann, S.6    Brandenburger, A.7
  • 51
    • 4644254242 scopus 로고    scopus 로고
    • Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucle-otides
    • Hiraoka K., Yamamoto S., Otsuru S., Nakai S., Tamai K., Morishita R., Ogihara T., et al. (2004) Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucle-otides J Immunol 173, 4297–307.
    • (2004) J Immunol , vol.173 , pp. 4297-4307
    • Hiraoka, K.1    Yamamoto, S.2    Otsuru, S.3    Nakai, S.4    Tamai, K.5    Morishita, R.6    Ogihara, T.7
  • 52
    • 7044225938 scopus 로고    scopus 로고
    • Dendritic cells fused with human cancer cells: Morphology, antigen expression, and T cell stimulation
    • Koido S., Ohana M., Liu C., Nikrui N., Durfee J., Lerner A., and Gong J. (2004) Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation Clin Immunol 113, 261–9.
    • (2004) Clin Immunol , vol.113 , pp. 261-269
    • Koido, S.1    Ohana, M.2    Liu, C.3    Nikrui, N.4    Durfee, J.5    Lerner, A.6    Gong, J.7
  • 53
    • 0036305621 scopus 로고    scopus 로고
    • Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: Evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination
    • Galea-Lauri J., Darling D., Mufti G., Harrison P., and Farzaneh F. (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination Cancer Immunol Immunother 51, 299–310.
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 299-310
    • Galea-Lauri, J.1    Darling, D.2    Mufti, G.3    Harrison, P.4    Farzaneh, F.5
  • 54
    • 0034254702 scopus 로고    scopus 로고
    • Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
    • Gong J., Nikrui N., Chen D., Koido S., Wu Z., Tanaka Y., Cannistra S., et al. (2000) Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity J Immunol 165, 1705–11.
    • (2000) J Immunol , vol.165 , pp. 1705-1711
    • Gong, J.1    Nikrui, N.2    Chen, D.3    Koido, S.4    Wu, Z.5    Tanaka, Y.6    Cannistra, S.7
  • 55
    • 0034646220 scopus 로고    scopus 로고
    • Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
    • Gong J., Avigan D., Chen D., Wu Z., Koido S., Kashiwaba M., and Kufe D. (2000) Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells Proc Natl Acad Sci USA 97, 2715–8.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 2715-2718
    • Gong, J.1    Avigan, D.2    Chen, D.3    Wu, Z.4    Koido, S.5    Kashiwaba, M.6    Kufe, D.7
  • 56
    • 27144435570 scopus 로고    scopus 로고
    • Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use
    • Koido S., Nikrui N., Ohana M., Xia J., Tanaka Y., Liu C., Durfee J. K., et al. (2005) Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use Gynecol Oncol 99, 462–71.
    • (2005) Gynecol Oncol , vol.99 , pp. 462-471
    • Koido, S.1    Nikrui, N.2    Ohana, M.3    Xia, J.4    Tanaka, Y.5    Liu, C.6    Durfee, J.K.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.